Results 121 to 130 of about 436,511 (214)

Dengue vaccine endgame: why has the global response to exponential demand in the tropics been so slow?

Frontiers in Tropical Diseases
IntroductionThere has been a dramatic global surge in dengue fever (DF) in recent years, with a projected 100-400 million cases annually and large outbreaks expected every 3-4 years.
Cristina Possas, Ernesto T. A. Marques, Ernesto T. A. Marques, Alessandra Oliveira, Suzanne Schumacher, Adelaide Antunes, Adelaide Antunes, Akira Homma   +7 more
doaj   +1 more source

The dengue vaccine dilemma [PDF]

The Lancet Infectious Diseases, 2018
openaire   +2 more sources

Estudo in vitro das citocinas envolvidas na resposta inflamatória de macrófagos murinos à infecção pelo vírus da dengue. [PDF]

, 2012
TCC(graduação) - Universidade Federal de Santa Catarina. Centro de Ciências Biológicas. Biologia.A dengue é uma doença que tem como agente etiológico o Dengue virus (DENV), da família Flaviviridae, do gênero Flavivirus.
Souza, Ingrid Larissa Melo de
core  

Analysis of the evidence about the efficacy and safety of the CYD-TDV dengue vaccine and its potential licensing and implementation within the Mexican Universal Vaccination Program

Salud Pública de México, 2016
Dengue is a major global public health problem which affects Latin America and Mexico. The prevention and control measures focusing on epidemiological surveillance and vector control have been partially effective as well as costly; thus, the development ...
Mauricio Hernández-Ávila, José Ignacio Santos-Preciado   +1 more
doaj  

Dengue vaccines

, 2013
Scott B. Halstead, Stephen J. Thomas
openaire   +1 more source

Dengue vaccine: a hidden risk to Aedes aegypti control in Brazil. [PDF]

Osong Public Health Res Perspect
Golias HC.
europepmc   +1 more source

Safety of Dengue Vaccine? [PDF]

Clin Infect Dis, 2023
Biswal S, Patel SS, Rauscher M.
europepmc   +2 more sources

Introduction of the dengue vaccine in Brazil: the importance of a strengthened Unified Health System in confronting arboviruses. [PDF]

Rev Lat Am Enfermagem
Maciel ELN, Gadelha CAG, Fernandes EG, Percio J, Araújo ACM, Victer TNDF, Cunha RVD, Werneck GL, Lima NT.   +8 more
europepmc   +1 more source

Mapping immune responses to TAK-003 dengue vaccine: immunogenicity across the clinical development program. [PDF]

Front Immunol
Mandaric S, El Hindi T, Nascimento EJM, Saez-Llorens X, Borja-Tabora C, Friberg H, Tricou V, Roubinis N, Gottardo R, Currier JR, Sharma M, Biswal S.   +11 more
europepmc   +1 more source

TAK-003 Dengue Vaccine Safety: Evidence from a Systematic Review and Meta-analysis of Clinical Trials. [PDF]

Indian J Community Med
Kumar R, Singh S, Maharshi V.
europepmc   +1 more source